Rebecca Assaraf, Editor

About the Author Rebecca Assaraf, Editor


Glu Mobile Inc. (GLUU) Partners with WWE for the Making of New Wrestling Game: Another Tap Sports Baseball Phenomenon Ahead?

Just two days ago, Glu Mobile Inc. (NASDAQ:GLUU) announced it had entered into a multi-year partnership with global entertainment leader WWE to develop …

Oracle Corporation (ORCL) Gets Price Target Boost on Excellent Earnings Results, Snap Inc (SNAP) Introduces Its Soon-To-Be “Big Hit”

Oracle Sees Strong Q4 Driven by Cloud Growth Oracle Corporation (NYSE:ORCL) reported excellent fiscal fourth-quarter results and reiterated its double-digit EPS growth guidance for …

Piper Jaffray Remains Sidelined on Nike Inc (NKE) Ahead of Upcoming Earnings Report

With Nike Inc (NYSE:NKE) preparing to release fiscal fourth-quarter earnings on Thursday, June 29, Piper Jaffray analyst Erinn Murphy remains relatively cautious on the stock. The …

Novadaq Technologies Inc. (NVDQ) Acquisition Could Spark a Bidding War

Yesterday, Novadaq Technologies Inc.(NASDAQ:NVDQ) shares skyrocketed 95% after the company announced it entered an ultimate agreement with Stryker Corp.

$100 Million Deal That Will Make Snap Inc Great Again?

Yesterday, Snap Inc (NYSE:SNAP) signed a “big” $100 million deal with Time Warner, agreeing to broadcast up to 10 original shows per year …

Pandora Media Inc (P) Redirects Attention to Fundamentals; Aegis Lowers Price Target

SiriusXM’s $480 million investment into Pandora Media Inc (NYSE:P) obviously ends any takeout speculation. As such, Aegis Capital analyst Victor Anthony lowered his price target …

BMO Capital Remains Sidelined on Nokia Oyj (ADR) (NOK) Following Router Launch Event

Yesterday, BMO Capital analyst Tim Long attended Nokia Oyj (ADR) (NYSE:NOK)’s router launch event, where the telecom giant introduced to the world its brand …

William Blair Shares Two Cents on Endo International plc (ENDP)

William Blair analyst Tim Lugo reiterates a Market Perform rating on shares of Endo International plc (NASDAQ:ENDP), following the news that the FDA has requested the …

Chardan Capital Slashed Price Target on Regulus Therapeutics Inc (RGLS) Following Program Discontinuations

Yesterday, Regulus Therapeutics Inc (NASDAQ:RGLS) disclosed unpleasant updates regarding the company’s pipeline. The drug maker announced three program discontinuations, which include drugs: RG-101, a …

Coherus Biosciences Inc (CHRS) Hits ‘Speed Bump’ for CHS-1701; Maxim Remains Positive

Yesterday, Coherus Biosciences Inc (NASDAQ:CHRS) received a Complete Response Letter (CRL) from the FDA for its Biologics License Application (BLA) on CHS-1701, a …